Note that Horizon 2020 requires PCP procurements to cover three R&D phases that cover solution exploration and design, prototyping, original development, and validation/testing of a limited volume of first products or services in the form of a test series.
We expect TRL8 at the end of phase 3. It is important to note that the procurers in PCPs may also be interested in buying (yet through another subsequent procedure) commercial volumes of the innovative solutions. It is therefore important that suppliers could perform (e.g., in parallel with PCP) the actions (e.g., certification/labelling/IPR protection) that are necessary for the commercial roll out of the innovative solutions.
If you would like to better understand what is expected in INCAREHEART have a look at this detailed description of the building blocks and use cases. Please note that this is draft information with the purpose of consulting the market and that it might differ from the final versions included in the Call for Tenders.
The OMC questionnaire aims to obtain market feedback on the planned PCP and assess existing solutions. The collected input will inform the ongoing tender specifications development. Let us know what you think before the 31st of August 2021.
If you are searching partners for a joint tender and would like to appear on the Matchmaking section of this website, you can register by completing the OMC questionnaire. This part of the questionnaire will remain open until the closure of the Call for Tenders.